Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study

Medicine and Dentistry

• Central Nervous System Tumor 100%
• Skin Manifestation 100%
• Patient 100%
• Child 100%
• Targeted Therapy 100%
• Cross Sectional Study 100%
• Mammalian Target of Rapamycin Inhibitor 80%
• MEK Inhibitor 80%
• Combination Therapy 60%
• Skin Examination 60%
• Therapeutic Procedure 60%
• Adverse Event 40%
• Age 40%
• Pediatrics 40%
• Surveillance 20%
• Early Intervention 20%
• Group Therapy 20%
• Follow up 20%
• Dermatological Agent 20%
• Monotherapy 20%
• Acneiform Eruption 20%
• Everolimus 20%
• Dabrafenib 20%
• Trametinib 20%
• Drug Dose Reduction 20%
• Life 20%
• Mitogen-Activated Protein Kinase 20%
• Quality of Life 20%
• Photograph 20%
• Cancer Treatment 20%